DavidsonX: Preclinical Safety: From In Vitro Assays to Human Dose Predictions

- Certification
- Certificate of completion
- Duration
- 3 weeks
- Price Value
- $ 199
- Difficulty Level
- Intermediate
This comprehensive course on preclinical safety offers students an in-depth exploration of the crucial methods and processes involved in quantifying the safety of potential drugs. Designed by DavidsonX, this intermediate-level course in the field of Medicine provides a thorough understanding of the intricate world of drug safety assessment, from initial testing to post-approval monitoring.
While there are no strict prerequisites, students should have a solid understanding of human anatomy. Knowledge of pharmacodynamics and pharmacokinetics will be beneficial for grasping the course content more effectively.
This course is ideal for students and professionals in the pharmaceutical industry, medical researchers, toxicologists, and anyone interested in understanding the intricacies of drug safety assessment. It is particularly suited for those looking to advance their knowledge in preclinical safety testing and drug development processes.
The skills acquired in this preclinical-safety-course are directly applicable to various roles in the pharmaceutical and biotechnology industries. Learners will be equipped to:
This course offers a unique opportunity to gain expertise in drug-safety-methods, safety-testing-programs, and safety-risks-assessment. By understanding the intricate balance between efficacy-vs-safety-risks and mastering techniques such as in-vitro-safety-assays and in-vivo-safety-studies, students will be well-prepared to contribute to the ever-evolving field of drug development and safety monitoring.
Explore more courses to enhance your cloud computing and Kubernetes skills.
Drugs are approved based on their “safety and efficacy”. Determining the safety of a drug occurs through studies that are largely completely separate from efficacy studies. The safety studies fall under the umbrella of preclinical safety. While a drug’s therapeutic benefit is typically narrow and well-defined, the potential safety risks of a compound can be very broad. Preclinical studies therefore search broadly in order to reveal any possible safety issues in a compound. Safety studies ultimately determine dosing limits for clinical trials as well as the final approved drug product.